12:30-13:20
|
µî·Ï ¹× Àü½Ã°ü¶÷
|
|
13:20-13:30
|
°³È¸
|
ȸÀå Á¶ÇÑÀÍ |
|
|
|
Topic (1)
|
|
[ÁÂÀå : ÀÌ°©³ë,
±è´ë¿ø]
|
13:30-13:50
|
Annual report of apheresis registration in KSFA
|
¼¿ïÀÇ´ë ÇѱԼ· |
13:50-14:10
|
Çѱ¹ÀÇ Donor apheresis ÇöȲ
|
´ëÇÑÀû½ÊÀÚ»ç µ¿ºÎÇ÷¾×¿ø Á¤È·É
|
14:10-14:30
|
Review of activity of WAA, ISFA and ASFA
|
°Ç±¹ÀÇ´ë ¼ÛÀº¿µ
|
14:30-15:00
|
¹éÇ÷±¸ ¹× ÀûÇ÷±¸ ¼ººÐäÁý ÇåÇ÷ ±âÁØ
|
¾ÆÁÖÀÇ´ë ÀÓ¿µ¾Ö
|
15:00-15:30
|
Coffee Break
|
|
|
|
|
Topic (2)
|
|
[ÁÂÀå : ÀÌÁ¾¿í,
¼Àå¼ö]
|
15:30-16:00
|
Use of gene expression profiling to assess the quality of
dendritic
cells prepared from fresh and stored leukapheresis products.
|
¼øõÇâÀÇ´ë ½ÅÁ¤¿ø
|
16:00-16:30
|
Á¶Ç÷¸ð¼¼Æ÷ °¡µ¿È(mobilization)¸¦ À§ÇÑ G-CSF Åõ¿©½Ã °ø¿©ÀÚ À¯ÇØ»ç·Ê
(adverse events)¿Í äÁýµÇ´Â CD34 ¾ç¼º ¼¼Æ÷ ¼ö¿ÍÀÇ »ó°ü¼º Æò°¡
|
¼¿ïÀÇ´ë ÃÖÁö¼±, ÇѱԼ·
|
16:30-17:00
|
Expanding Indications for Therapeutic Apheresis
|
¿ï»êÀÇ´ë ±Ç¼®¿î
|
17:00-17:30
|
Comparison of membrane filtration to centrifugation for therapeutic
plasma exchange
|
¼¿ïÀÇ´ë ÃÖÁö¼±, ÇѱԼ·
|
17:30-17:50
|
ÃÑȸ ¹× Æóȸ
|
|